Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rapid Micro Biosystems (RPID) Invested Capital (2020 - 2025)

Rapid Micro Biosystems' Invested Capital history spans 6 years, with the latest figure at $44.3 million for Q3 2025.

  • For Q3 2025, Invested Capital fell 47.46% year-over-year to $44.3 million; the TTM value through Sep 2025 reached $44.3 million, down 47.46%, while the annual FY2024 figure was $75.4 million, 36.14% down from the prior year.
  • Invested Capital for Q3 2025 was $44.3 million at Rapid Micro Biosystems, down from $54.5 million in the prior quarter.
  • Across five years, Invested Capital topped out at $234.7 million in Q3 2021 and bottomed at -$164.5 million in Q2 2021.
  • The 5-year median for Invested Capital is $118.0 million (2023), against an average of $102.5 million.
  • The largest YoY upside for Invested Capital was 306.25% in 2021 against a maximum downside of 59.38% in 2021.
  • A 5-year view of Invested Capital shows it stood at $221.0 million in 2021, then dropped by 25.71% to $164.2 million in 2022, then decreased by 28.13% to $118.0 million in 2023, then plummeted by 36.14% to $75.4 million in 2024, then tumbled by 41.17% to $44.3 million in 2025.
  • Per Business Quant, the three most recent readings for RPID's Invested Capital are $44.3 million (Q3 2025), $54.5 million (Q2 2025), and $65.5 million (Q1 2025).